Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
GN Hearing Norway AS
AS
Active
Org 912920437
Brynsveien 13, 0667
Oslo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 1967 · 59 years old
18 employees
Monitor
Share
Norway
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
GN Hearing Norway AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
IT
Ivar Thomsen
Chief Executive Officer
Chief Executive Officer
2022
Former (1)
BB
Bredo Berge
Chief Executive Officer
Chief Executive Officer
2015 – 2022
Board of directors
Non-executive oversight
Name
Role
Member since
Current (4)
IT
Ivar Thomsen
Board of Directors
Board of Directors
2022
PJ
Peter Justesen
Chairman
Chairman
2024
VU
Victor Ullerichs
Board of Directors
Board of Directors
2024
PG
Paul Gilbert Daft
Board of Directors
Board of Directors
2024
Former (5)
MC
Mikkel Carlsen Skovsted
Board of Directors
Board of Directors
2021 – 2022
AH
Anders Høst Lassen
Board of Directors
Board of Directors
2022 – 2024
TJ
Thomas John Woods
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on GN Hearing Norway AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
Board of Directors
Board of Directors
2022 – 2024
BB
Bredo Berge
Chairman
Chairman
2021 – 2022
SO
Stefan Olivier Witschi
Chairman
Chairman
2022 – 2024